Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5938 USD | -4.99% | +2.40% | -27.74% |
05-30 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
05-13 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.74% | 21.61M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Insider Buy: Forte Biosciences